Literature DB >> 9260802

Distribution of inducible nitric oxide synthase in ulcerative colitis.

I Ikeda1, T Kasajima, S Ishiyama, T Shimojo, Y Takeo, T Nishikawa, S Kameoka, M Hiroe, A Mitsunaga.   

Abstract

OBJECTIVE: To investigate reports that the biosynthesis of nitric oxide (NO) is increased in the colonic mucosa of patients with active ulcerative colitis (UC), which suggests that serum NOx levels may be an important indicator of UC activity.
METHODS: To determine the role of NO within the colon, we purchased polyclonal antibodies against human-inducible NO synthase (iNOS). We then examined the distribution of iNOS-reactive cells in UC colon tissues.
RESULTS: In specimens from 12 UC patients, iNOS-positive neutrophils and macrophages were observed at the base of the ulcer but not in distant areas in the active stage. iNOS expression in colon mucosa was virtually absent during the inactive stage of UC and within the colon of patients with non-UC colitis.
CONCLUSIONS: We conclude that NO in colonic mucosa may play a potential role in the pathogenesis of UC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9260802

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  21 in total

1.  Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP.

Authors:  M Cavicchi; B J Whittle
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Peroxynitrite and inflammatory bowel disease.

Authors:  D M McCafferty
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

Review 3.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

4.  Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders.

Authors:  Tryggve Ljung; Sofie Lundberg; Mark Varsanyi; Catharina Johansson; Peter T Schmidt; Max Herulf; Jon O Lundberg; Per M Hellstrom
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 5.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

6.  5-Aminoisoquinolinone reduces colon injury by experimental colitis.

Authors:  Salvatore Cuzzocrea; Emanuela Mazzon; Rosanna Di Paola; Tiziana Genovese; Nimesh S A Patel; Carmelo Muià; Michael D Threadgill; Angelina De Sarro; Christoph Thiemermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-18       Impact factor: 3.000

7.  Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; H Mota-Filipe; T Centorrino; M L Terranova; A Ciccolo; D Britti; A P Caputi; C Thiemermann
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

8.  The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon.

Authors:  P J Roberts; G P Riley; K Morgan; R Miller; J O Hunter; S J Middleton
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

9.  Induction of iNOS in a rat model of acute colitis.

Authors:  E Kankuri; M Z Asmawi; R Korpela; H Vapaatalo; E Moilanen
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

10.  Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis.

Authors:  Joshua-Ka-Shun Ko; Flora-Ying-Lee Lam; Andrew-Pok-Lap Cheung
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.